Fig. 3. Sequence of the GPV gene promoter and DNA fragments of the 5′-flanking sequence used for DNase I protection assays. The GPV promoter was numbered from an arbitrary start site common to Dami cells and platelets, which conforms to the consensus start of platelet TATA-less gene (Table 2). (A) Alignment of the fragments I to VII with the −1432/+21 GPV 5′-flanking segment. The fragments were checked by sequencing before 5′-end-labeling and use in DNase I protection assays. Footprinting analyses of III, IV, VI, and VII are reported in Figs 4 through 7. (B) Sequence of the GPV promoter. The transcription start site is denoted +1, the intron sequence is in lowercase characters, and the intron donor splice site is in bold characters.
Fig. 3.

Sequence of the GPV gene promoter and DNA fragments of the 5′-flanking sequence used for DNase I protection assays. The GPV promoter was numbered from an arbitrary start site common to Dami cells and platelets, which conforms to the consensus start of platelet TATA-less gene (Table 2). (A) Alignment of the fragments I to VII with the −1432/+21 GPV 5′-flanking segment. The fragments were checked by sequencing before 5′-end-labeling and use in DNase I protection assays. Footprinting analyses of III, IV, VI, and VII are reported in Figs 4 through 7. (B) Sequence of the GPV promoter. The transcription start site is denoted +1, the intron sequence is in lowercase characters, and the intron donor splice site is in bold characters.

or Create an Account

Close Modal
Close Modal